Global Interstitial Lung Disease Market Set to Reach USD 3.2 Billion by 2032, Fueled by Rising IPF Prevalence, Aging Populations. The Interstitial Lung Disease Market is entering a high-impact growth phase, propelled by the escalating global burden of fibrotic lung conditions, demographic aging trends, and the accelerating clinical adoption of next-generation anti-fibrotic and biologic therapies. […]








